Logo image of PFSW

PFSWEB INC (PFSW) Stock Fundamental Analysis

NASDAQ:PFSW - Nasdaq - US7170982067 - Common Stock - Currency: USD

7.49  0 (0%)

Fundamental Rating

2

Taking everything into account, PFSW scores 2 out of 10 in our fundamental rating. PFSW was compared to 82 industry peers in the IT Services industry. While PFSW seems to be doing ok healthwise, there are quite some concerns on its profitability. PFSW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PFSW has reported negative net income.
PFSW had a positive operating cash flow in the past year.
In multiple years PFSW reported negative net income over the last 5 years.
In multiple years PFSW reported negative operating cash flow during the last 5 years.
PFSW Yearly Net Income VS EBIT VS OCF VS FCFPFSW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

1.2 Ratios

PFSW has a Return On Assets (-3.72%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -7.48%, PFSW is in line with its industry, outperforming 48.86% of the companies in the same industry.
Industry RankSector Rank
ROA -3.72%
ROE -7.48%
ROIC N/A
ROA(3y)11.48%
ROA(5y)6.81%
ROE(3y)13.5%
ROE(5y)7.67%
ROIC(3y)N/A
ROIC(5y)N/A
PFSW Yearly ROA, ROE, ROICPFSW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 20 40 60

1.3 Margins

PFSW has a worse Gross Margin (16.12%) than 90.91% of its industry peers.
In the last couple of years the Gross Margin of PFSW has declined.
PFSW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-9.6%
PFSW Yearly Profit, Operating, Gross MarginsPFSW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

PFSW does not have a ROIC to compare to the WACC, probably because it is not profitable.
PFSW has more shares outstanding than it did 1 year ago.
The debt/assets ratio for PFSW has been reduced compared to a year ago.
PFSW Yearly Shares OutstandingPFSW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
PFSW Yearly Total Debt VS Total AssetsPFSW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.29 indicates that PFSW is not a great score, but indicates only limited risk for bankruptcy at the moment.
PFSW has a Altman-Z score (2.29) which is in line with its industry peers.
A Debt/Equity ratio of 0.00 indicates that PFSW is not too dependend on debt financing.
PFSW has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PFSW outperforms 85.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.29
ROIC/WACCN/A
WACC10.54%
PFSW Yearly LT Debt VS Equity VS FCFPFSW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

2.3 Liquidity

PFSW has a Current Ratio of 1.76. This is a normal value and indicates that PFSW is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PFSW (1.76) is comparable to the rest of the industry.
A Quick Ratio of 1.76 indicates that PFSW should not have too much problems paying its short term obligations.
PFSW has a Quick ratio of 1.76. This is comparable to the rest of the industry: PFSW outperforms 56.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.76
PFSW Yearly Current Assets VS Current LiabilitesPFSW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PFSW have decreased strongly by -104.22% in the last year.
Looking at the last year, PFSW shows a small growth in Revenue. The Revenue has grown by 5.08% in the last year.
Measured over the past years, PFSW shows a decrease in Revenue. The Revenue has been decreasing by -2.02% on average per year.
EPS 1Y (TTM)-104.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)5.08%
Revenue growth 3Y0.13%
Revenue growth 5Y-2.02%
Sales Q2Q%5.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PFSW Yearly Revenue VS EstimatesPFSW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M
PFSW Yearly EPS VS EstimatesPFSW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 0.2 -0.2 0.4 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PFSW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFSW Price Earnings VS Forward Price EarningsPFSW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PFSW Per share dataPFSW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 60.08%, PFSW is a good candidate for dividend investing.
PFSW's Dividend Yield is rather good when compared to the industry average which is at 2.94. PFSW pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, PFSW pays a better dividend.
Industry RankSector Rank
Dividend Yield 60.08%

5.2 History

PFSW is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PFSW Yearly Dividends per sharePFSW Yearly Dividends per shareYearly Dividends per share 2022 1 2 3 4

5.3 Sustainability

PFSW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1655.05%
EPS Next 2YN/A
EPS Next 3YN/A
PFSW Yearly Income VS Free CF VS DividendPFSW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

More info and screens

PFSWEB INC

NASDAQ:PFSW (10/23/2023, 8:00:01 PM)

7.49

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-08 2023-08-08/amc
Earnings (Next)11-07 2023-11-07/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners5.11%
Ins Owner Change0%
Market Cap167.70M
Analysts43.33
Price Target7.65 (2.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 60.08%
Yearly Dividend4.56
Dividend Growth(5Y)N/A
DP-1655.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.82%
PT rev (3m)-31.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF 21.05
P/B 1.96
P/tB 2.64
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.36
OCFY4.75%
SpS13.45
BVpS3.81
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.72%
ROE -7.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.12%
FCFM N/A
ROA(3y)11.48%
ROA(5y)6.81%
ROE(3y)13.5%
ROE(5y)7.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-9.6%
F-Score6
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 110.62%
Cap/Sales 2.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.76
Altman-Z 2.29
F-Score6
WACC10.54%
ROIC/WACCN/A
Cap/Depr(3y)93.26%
Cap/Depr(5y)72.19%
Cap/Sales(3y)2.49%
Cap/Sales(5y)2.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.08%
Revenue growth 3Y0.13%
Revenue growth 5Y-2.02%
Sales Q2Q%5.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-359.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.27%
OCF growth 3YN/A
OCF growth 5YN/A